Evidence map›Paper›PMID 35163169›Full record

ReviewInternational journal of molecular sciences2022

Mechanistic Insights of Chelator Complexes with Essential Transition Metals: Antioxidant/Pro-Oxidant Activity and Applications in Medicine.

Viktor A Timoshnikov, Olga Yu Selyutina, Nikolay E Polyakov, Victoria Didichenko, George J Kontoghiorghes

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Transmetalation in Cancer Pharmacology.International journal of molecular sciences · 2025
    Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Viktor A TimoshnikovInstitute of Chemical Kinetics & Combustion, 630090 Novosibirsk, Russia.ORCID 0000-0001-8753-5304
Olga Yu SelyutinaInstitute of Chemical Kinetics & Combustion, 630090 Novosibirsk, Russia.ORCID 0000-0003-3686-7274
Nikolay E PolyakovInstitute of Chemical Kinetics & Combustion, 630090 Novosibirsk, Russia.ORCID 0000-0002-3666-7750
Victoria DidichenkoPostgraduate Research Institute of Science, Technology, Environment and Medicine, Limassol 3021, Cyprus.
George J KontoghiorghesPostgraduate Research Institute of Science, Technology, Environment and Medicine, Limassol 3021, Cyprus.ORCID 0000-0002-3364-7340
Institute of Chemical Kinetics and Combustion · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The antioxidant/pro-oxidant activity of drugs and dietary molecules and their role in the maintenance of redox homeostasis, as well as the implications in health and different diseases, have not yet been fully evaluated. In particular, the redox activity and other interactions of drugs with essential redox metal ions, such as iron and copper, need further investigation. These metal ions are ubiquitous in human nutrition but also widely found in dietary supplements and appear to exert major effects on redox homeostasis in health, but also on many diseases of free radical pathology. In this context, the redox mechanistic insights of mainly three prototype groups of drugs, namely alpha-ketohydroxypyridines (alpha-hydroxypyridones), e.g., deferiprone, anthraquinones, e.g., doxorubicin and thiosemicarbazones, e.g., triapine and their metal complexes were examined; details of the mechanisms of their redox activity were reviewed, with emphasis on the biological implications and potential clinical applications, including anticancer activity. Furthermore, the redox properties of these three classes of chelators were compared to those of the iron chelating drugs and also to vitamin C, with an emphasis on their potential clinical interactions and future clinical application prospects in cancer, neurodegenerative and other diseases.

Indexed as

AnthraquinonesAntioxidantsChelating AgentsCoordination ComplexesCopperDoxorubicinFree RadicalsIronIron Chelating AgentsOxidation-ReductionPyridinesReactive Oxygen SpeciesThiosemicarbazonesTransition ElementsAnthraquinonesAntioxidantsChelating AgentsCoordination ComplexesCopperDoxorubicinFree RadicalshydroxypyridinesIronIron Chelating AgentsPyridinesReactive Oxygen SpeciesThiosemicarbazonesTransition Elementsalpha-ketohydroxypyridinesanthraquinonesantioxidant activityascorbic acidchelatorshydroxypyridonespro-oxidant activityreactive oxygen speciesthiosemicarbazonestransition metals

Identifiers

PMID35163169
PMCPMC8835618
OpenAlexW4206965938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.